Home Physical Sciences The crystal structure of tert-butyl (tert-butoxy(oxo)methyl)(5-bromo-2-fluorophenyl)carbamate, C16H21BrFNO4
Article Open Access

The crystal structure of tert-butyl (tert-butoxy(oxo)methyl)(5-bromo-2-fluorophenyl)carbamate, C16H21BrFNO4

  • Chun Ji ORCID logo EMAIL logo and Yu-Mei Qin
Published/Copyright: October 19, 2019

Abstract

C16H21BrFNO4, monoclinic, P21/n (no. 14), a = 9.0896(4) Å, b = 10.8609(4) Å, c = 18.5637(8) Å, β = 99.5050(10)°, V = 1807.47(13) Å3, Z = 4, Rgt(F) = 0.0382, wRref(F2) = 0.0900, T = 170 K.

CCDC no.: 1947033

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.15 × 0.12 × 0.08 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:2.30 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:27.5°, 98%
N(hkl)measured, N(hkl)unique, Rint:16818, 4042, 0.070
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2964
N(param)refined:214
Programs:Bruker [1], Olex2 [2], SHELX [3], [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Br10.08101(3)0.81476(3)0.58939(2)0.04502(11)
C10.3921(3)0.8979(2)0.42197(13)0.0292(5)
C20.3234(3)0.9940(2)0.45152(14)0.0355(6)
H20.3400621.0765080.4378090.043*
C30.2302(3)0.9693(2)0.50120(14)0.0341(6)
H30.1818231.0346840.5220260.041*
C40.2077(3)0.8490(2)0.52044(13)0.0300(6)
C50.2778(3)0.7528(2)0.49093(13)0.0279(5)
H50.2618730.6703640.5049140.034*
C60.3705(3)0.7771(2)0.44132(13)0.0255(5)
C70.6006(3)0.6850(2)0.41793(13)0.0255(5)
C80.8118(3)0.6303(2)0.35852(13)0.0274(5)
C90.8979(3)0.5643(3)0.42365(15)0.0410(7)
H9A0.8944270.6125860.4679170.062*
H9B1.0018890.5542210.4168350.062*
H9C0.8534010.4831380.4284970.062*
C100.8156(3)0.5585(3)0.28890(15)0.0436(7)
H10A0.7766120.4753920.2939080.065*
H10B0.9186780.5532250.2798760.065*
H10C0.7541000.6005040.2478650.065*
C110.8665(4)0.7603(2)0.35220(19)0.0516(8)
H11A0.8018290.8025930.3123440.077*
H11B0.9688920.7586090.3419940.077*
H11C0.8643580.8041680.3981400.077*
C120.3515(3)0.5923(2)0.36673(12)0.0249(5)
C130.3585(3)0.3850(2)0.31694(13)0.0274(5)
C140.3485(3)0.4322(2)0.23974(13)0.0380(6)
H14A0.2724670.4968230.2308190.057*
H14B0.3213980.3643890.2052820.057*
H14C0.4453280.4660180.2330360.057*
C150.4763(3)0.2860(2)0.33381(15)0.0366(6)
H15A0.5727080.3183840.3254910.055*
H15B0.4487320.2149230.3019320.055*
H15C0.4836840.2606630.3849490.055*
C160.2108(3)0.3409(2)0.33509(17)0.0422(7)
H16A0.2226080.3206470.3871700.063*
H16B0.1781930.2675110.3060850.063*
H16C0.1359200.4060580.3237500.063*
F10.48272(17)0.92160(13)0.37289(8)0.0397(4)
N10.4438(2)0.67936(17)0.40917(11)0.0274(4)
O10.22729(19)0.61699(14)0.33802(10)0.0335(4)
O20.41940(17)0.48426(13)0.36872(8)0.0259(4)
O30.65003(18)0.63117(15)0.36273(9)0.0317(4)
O40.67210(18)0.73847(15)0.46857(9)0.0303(4)

Source of material

5-Bromo-2-fluoroaniline (5 g, 26.31 mmol) was dissolved in THF (80 mL) at room temperature, followed by di-tert-butyl dicarbonate (17.23 g, 78.94 mmol) and dimethylaminopyridine (0.32 g, 2.63 mmol) in order. Then mixture reacted under stirring at room temperature for 12 hours. Subsequently, the mixture was poured into water and extracted with ethyl acetate. The organic phase was dehydrated with anhydrous sodium sulfate and concentrated at reduced pressure to afford a yellow solid. The crude mixture was purified by silica gel column chromatography, eluted with petroleum ether to give a white solid (6.45 g, yield 62.80%). 1H NMR (400 MHz, CDCl3) δ [ppm] 7.40 (ddd, J = 8.8, 4.3, 2.5 Hz, 1H), 7.33 (dd, J = 6.7, 2.5 Hz, 1H), 7.00 (t, J = 9.1 Hz, 1H), 1.43 (s, 18H). Crystals were grown in hexane at room temperature.

Experimental details

All hydrogen atoms were placed in geometrically calculated positions. The Uiso values of the hydrogen atoms were set to 1.5 Ueq(Cmethyl) and 1.2 Ueq (Caryl).

Comment

Some carbamates are of significant interest in medicine, organic synthesis and fine chemicals. They can participate in the synthesis of aniline derivatives as EP2 agonists useful in treating glaucoma [5]. At the same time, they can also be used for electrolyte solution of nonaqueous secondary batteries [6]. In addition, it can be chemoselectively and efficiently deprotected in high yields using a catalytic agent to afford the corresponding mono-BOC-protected amine [7], which is an intermediate for the preparation of antiviral agents [8], glycogen phosphorylase inhibitors [9] and antagonists of gonadotropin releasing hormone (GnRH) [10].

There is one molecule in the asymmetric unit (see the figure). The phenyl moiety connects the two tert-butoxycarbonyl groups via a nitrogen atom, respectively. All bond lengths and angles in the crystal structure are within the normal range [11]. The values of the selected torsion angles C(1)-C(6)-N(1)-C(7), C(1)-C(6)-N(1)-C(12), C(5)-C(6)-N(1)-C(7) and C(5)-C(6)-N(1)-C(12) are 57.15°, −117.80°, −123.31° and 61.74°, respectively. The crystal structure shows that the intermolecular packing is stabilized by weak hydrogen bonds and the van der Waals forces.

Acknowledgements

This work was supported by the Major Social Development Project of Guizhou Province (SY20143054).

References

1. BRUKER. SAINT, APEX2 and SADABS. Bruker AXS Inc., Madison, WI, USA (2009).Search in Google Scholar

2. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Search in Google Scholar

3. Sheldrick, G. M.: SHELXT-integrated space-group and crystal-structure determination. Acta Crystallogr. A71 (2015) 3–8.10.1107/S2053273314026370Search in Google Scholar PubMed PubMed Central

4. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central

5. Feutrill, J.; Leriche, C.; Middlemiss, D.: Preparation of aniline derivatives as EP2 agonists useful in treating glaucoma. PCT Int. Appl. (2013) WO 2013037705.Search in Google Scholar

6. Ishino, T.; Kodama, K.; Kinoshita, I.; Ishiji, Y.; Yawata, T.: Electrolyte solution for nonaqueous secondary batteries, and nonaqueous secondary battery. PCT Int. Appl. (2014) WO 2014156428.Search in Google Scholar

7. Zheng, J. L.; Yin, B. L.; Huang, W. M.; Li, X. P.; Yao, H. Q.; Liu, Z. G.; Zhang, J. C.; Jiang, S.: Efficient and selective cleavage of the t-butoxycarbonyl group from di-t-butylimidodicarbonate using catalytic bismuth(III) bromide in acetonitrile. Tetrahedron Lett. 50 (2009) 5094–5097.10.1016/j.tetlet.2009.06.104Search in Google Scholar

8. Pathak, A. K.; Ahmed, S. K.; Augelli-Szafran, C. E.; Maddry, J. A.: Preparation of benzo annulenes as antiviral agents. U.S. Pat. (2018) US 20180230084.Search in Google Scholar

9. Onda, K.; Shiraki, R.; Ogiyama, T.; Yokoyama, K.; Momose, K.; Katayama, N.; Orita, M.; Yamaguchi, T.; Furutani, M.; Hamada, N.: Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Bioorg. Med. Chem. 16 (2008) 10001–10012.10.1016/j.bmc.2008.10.021Search in Google Scholar PubMed

10. Ohno, K.; Miyagi, T.; Ozawa, T.; Fushimi, N.: Preparation of fused pyrimidine heterocyclic derivatives as antagonists of gonadotropin releasing hormone (GnRH). PCT Int. Appl. (2007) WO 2007046392.Search in Google Scholar

11. Capuano, B.; Crosby, I. T.; Forsyth, C. M.; Khakham, Y.; Manallack, D. T.: Di-tert-butyl N-[2,6-bis-(methoxymethoxy)phenyl]iminodiacetate. Acta Crystallogr. E65 (2009) o819.10.1107/S1600536809009246Search in Google Scholar PubMed PubMed Central

Received: 2019-08-19
Accepted: 2019-10-08
Published Online: 2019-10-19
Published in Print: 2019-12-18

©2019 Chun Ji et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Articles in the same Issue

  1. 10.1515/ncrs-2020-frontmatter1
  2. The crystal structure of 3,5-dicarboxybenzenaminium perchlorate monohydrate, C8H8ClNO9
  3. The crystal structure of poly[(m4-4-bromoisophthalato-κ4O: O′:O′′:O′′′)zinc(II)], C8H3BrO4Zn
  4. Crystal structure of (E)-2-(2-chloro-6-hydroxybenzylidene)hydrazine-1-carbothioamide, C8H8ClN3O4S
  5. Crystal structure of 1,1′-methylenebis(3-ethyl-1H-imidazol-3-ium) bis(hexafluorophosphate(V)), C11H18F12N4P2
  6. The crystal structure of hexakis(1-isopropyl-1H-imidazole-κ1N)copper(II) dichloride, C36H58Cl2CuN12
  7. Crystal structure of catena-poly[μ2-4,4′-bipyridine-κ2N:N′)-tetrakis(μ2-2-((3,5,6-trichloropyridin-2-yl)oxy)acetato-κ2O:O′)dicobalt(II)], C19H10Cl6CoN3O6
  8. Crystal structure of (E)-1-(4-(((E)-2-bromo-6-hydroxybenzylidene)amino)phenyl)ethan-1-one O-methyl oxime, C16H15BrN2O2
  9. Crystal structure of ethyl 2-methyl-4-(5-methylthiophen-2-yl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C18H21NO3S
  10. The crystal structure of 5-bromo-2-(1-methyl-1H-tetrazol-5-yl)pyridine, C7H6BrN5
  11. Crystal structure of Bis(acetato-κ2O,O′)-bis[4-(dimethylamino)pyridine-κN]nickel(II), C18H26N4NiO4
  12. Crystal structure of (E)-3-chloro-2-(((4-chlorophenyl)imino)methyl)phenol, C13H9Cl2NO
  13. The co-crystal structure of (17b)-estra-1,3,5(10)-triene-3,17diol – acetamide (1/1), a Z′ = 4 structure, C20H29NO3
  14. Crystal structure of 3-(3-(pyridin-3-yl)ureido)benzoic acid, C13H11N3O3
  15. The crystal structure of 1,1′-(9-ethyl-9H-carbazole-3,6-diyl)bis(3-ethyl-1H-imidazol-3-ium) bis(hexafluorophosphate(IV)), C24H27N5F12P2
  16. The crystal structure of 2-bromoisophthalic acid, C8H5BrO4
  17. The crystal structure of 13-ethoxycarbonyl-9-methyl-4-chlor-11-thioxo-8-oxa-10,12-diazatricyclo[7.3.1.02,7]trideca-2,4,6-triene, C14H15ClN2O3S
  18. The crystal structure of (E)-4-((4-(diethylamino)benzylidene)amino)-N,N-diphenylaniline, C29H29N3
  19. Crystal structure of 2-(3-(2-(4-phenylpiperazin-1-yl)ethyl)benzyl)isoindoline-1,3-dione, C27H27N3O2
  20. Crystal structure of 2-ethoxy-6-((E)-((3-(((E)-3-ethoxy-2-hydroxybenzylidene)amino)-2-hydroxypropyl)iminio)methyl)phenolate, C21H26N2O5
  21. The crystal structure of catena-poly2-4,4′-bipyridine-κ2N:N′)-tetrakis(μ2-2-((3,5,6-trichloropyridin-2-yl)oxy)acetato-κ2O:O′)dinickel(II)], C19H10Cl6N3NiO6
  22. Crystal structure of hexakis(μ2-azido-κ2N:N)-diazido-κ1N-tetrakis(phenanthroline-κ2N,N′)tetrazinc(II), C48H32N32Zn4
  23. Synthesis and crystal structure of bis{2-bromo-6-(((4-(1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}cobalt(II)–dichloromethane(1/1), C34H32Br2Cl4CoN4O4
  24. Crystal structure of (E)-3-chloro-2-(((4-nitrophenyl)imino)methyl)phenol, C13H9ClN2O3
  25. Crystal structure of aqua-bis(5-bromo-6-methyl-picolinato-κ2N,O)zinc(II) dihydrate, C14H16Br2N2O7Zn
  26. Crystal structure of biaqua(2,2′-bipyridine-4,4′-dicarboxylato-κ2N,N′)(pyridine-2,6-dicarboxylato-κ3O,N,O′)nickel(II) hydrate, C19H15N3NiO10
  27. Synthesis and crystal structure of bis(2-(((4-(1-(ethoxyimino)ethyl)phenyl)imino)methyl)-5-fluorophenolato-κ2N,O)zinc(II) - methanol (1/1), C33H32F2N4O4Zn
  28. Crystal structure of tetraaqua-bis(μ2-5-aminoisophthalato-κ3N:O,O′)-bis(4,4′-dipyridylsulfide-κ1N)dizinc(II), C36H34N6O12S2Ni2
  29. Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)palladium(II) tetracyanonickelate(II), C14H24N8NiPd
  30. The crystal structure of 3-benzyl-1-((8-(benzyloxy)quinolin-2-yl)methyl)-1H-imidazol-3-ium hexafluorophosphate, C27H24N3OF6P
  31. Crystal structure of 1-(4-chloro-2-hydroxy-5-iodophenyl)ethan-1-one, C8H6ClIO2
  32. Crystal structure of hexaaquamagnesium(II) bis((E)-4-((4-(dimethylamino)phenyl)diazenyl)benzenesulfonate), C28H40MgN6O12S2
  33. Crystal structure of the coordination polymer catena-poly[(1,2-di(pyridin-4-yl)ethane-κN)-(μ2-2-nitroisophthalato-κ2O:O′)zinc(II)], C20H17N3O7Zn
  34. Crystal structure of catena-{[tri-aqua-di-sodium bis(2-{[n-butyl(methyl)carbamothioyl]sulfanyl}acetate)]}n, [C16H34N2Na2O7S4]n
  35. The crystal structure of diaqua-bis(μ2-3-((3-acetyl-5-carboxyphenyl)oxidophosphoryl)-5-carboxybenzoato-κ2O:O′)bis(5,5′-dimethyl-2,2′-bipyridine-k2N,N′)zinc(II), C56H46N4O22P2Zn2
  36. Crystal structure of N′,2-bis((E)-2-chloro-6-hydroxybenzylidene)hydrazine-1-carbothiohydrazide, C15H12Cl2N4O2S
  37. Crystal structure of 2-[(1E)-{[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]iminiumyl}methyl]-5-(dodecyloxy)benzen-1-olate, C23H39NO5
  38. Crystal structure of 12-(2-hydroxybenzoyl)benzo[f]pyrido[1,2-a]indole-6,11-dione, C23H13NO4
  39. Crystal structure of chlorido-(4-chloro-6-(p-tolyl)pyrimidine-κ2C,N)-(triphenylphosphane-κP)palladium(II), C29H23Cl2N2PPd
  40. Crystal structure of catena-poly[diaqua-bis(3,4,5,6-tetrabromo-carboxybenzoato-κ1O)-(μ2-4,4′-bipyridine-κ2N:N′)cobalt(II)], C26H14Br8CoN2O10
  41. Crystal structure of catena-poly[dibenzyl-dichlorido-(μ2-[4,4′-bipyridine]1,1′-dioxide-κ2O:O′)tin(IV)], C24H22Cl2N2O2Sn
  42. Crystal structure of benzyl-chlorido-(4-chloro-N-[(2-oxidophenyl)methylidene]benzenecarbohydrazonato)-methanol-tin(IV), C22H20Cl2N2O3Sn
  43. Crystal structure of catena-poly[triaqua-(1,3-di(1H-imidazol-1-yl)benzene-κ2N:N′)-(3-nitrophthalato-κ1O)cobalt(II)] — water (2/3), C20H22N5O10.5Co
  44. Crystal structure of (3R,5R,8R,9R,10R,12R,13R,14R)-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol, C30H52O3
  45. Crystal structure of 3-(3-(4-carboxyphenyl)ureido)pyridin-1-ium perchlorate, C26H24Cl2N6O14
  46. Crystal structure of 8-hydroxy-2-methylquinolin-1-ium chloride dihydrate, C10H14ClNO3
  47. Crystal structure of (dibenzyl sulphoxide-κO)dibromido-bis(4-bromobenzyl-κC)tin(IV), C28H26Br4OSSn
  48. Crystal structure of bromido-tri(4-chlorophenyl-κ1C)-(ethanol-κ1O)tin(IV) — 4,4′-dimethyl-2,2′-bipyridine (2/1), C52H48Br2Cl6N2O2Sn2
  49. Crystal structure of 2-butyl-6-(ethylamino)-1H-benzo[de]isoquinoline-1,3(2H)-dione, C18H20N2O2
  50. Crystal structure of (4-chloro-N-[(2-oxido-5-chlorophenyl)methylidene] benzene-carbohydrazonato-κ3N,O,O′)bis(2-fluorobenzyl)tin(IV), C28H20Cl2F2N2O2Sn
  51. Crystal structure of aqua-chlorido-(4-fluorobenzyl-κC)-(N′-(4-methoxy-2-oxidobenzylidene)-3-hydroxy-2-naphthohydrazidato-κ3N,O,O′)tin(IV), C26H22ClFN2O5Sn
  52. Crystal structure of catena-poly[tri(4-chlorophenyl)-(μ2-hydroxido)tin(IV)] – 2-propanol (1/1), C21H21Cl3O2Sn
  53. Crystal structure of bromido-dimethyl-4-tolyl-(triphenylphosphine oxide)tin(IV), C27H28BrOPSn
  54. Crystal structure of 2-(bis(2-hydroxyethyl)ammonio)ethane-1-sulfonate, C6H15NO5S
  55. Crystal structure of bis[triaqua-(μ2-1,2-di(4-pyridyl)ethylene-κ2N:N′)-(4-sulfonatobenzoato-κ2O,O′)zinc(II)], C13H15NO8SZn
  56. Crystal structure of 2-((2-(3-hydroxy-7-methylene-2,3-dihydro-7H-furo[3,2-g]chromen-2-yl)propan-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol – a marmesin derivative, C20H24O10
  57. Crystal structure of octa(4-chlorobenzyl)-dichlorido-bis(μ2-methanolato)-bis(μ3-oxo)-tetratin(IV), C58H54Cl10O4Sn4
  58. Crystal structure of iodido-triphenyl-(triphenylphosphine oxide)tin(IV), C36H30IOPSn
  59. Crystal structure of dichlorido-bis(4-methylphenyl-κC)-bis(triphenylarsine oxide-κO)tin(IV), C50H44As2Cl2O2Sn
  60. Crystal structure of 4-benzyl-1-oxo-N-phenethyl-1H-[1,4]oxazino [4,3-b]indazole-3-carboxamide, C26H21N3O3
  61. Crystal structure of bis{(N-[(5-chloro-2-oxidophenyl)methylidene]-2-hydroxybenzenecarbohydrazonato)-dioxo-molybdenum(VI)}(μ2-4,4′-bipyridine), C38H26Cl2Mo2N6O10
  62. Crystal structure of dichlorido-octamethyl-bis(μ3-oxido)-bis(μ2-2-(phenylamino)ethanolato-κ2O:O)tetratin(IV), C24H44Cl2N2O4Sn4
  63. The crystal structure of 1-(2-(2-(imidazo[1,5-a]pyridine-4-ium)ethoxy)ethyl)-imidazo[1,5-a]pyridine-4-ium bis(hexafluorophosphate) — acetonitrile (1/1), C18H20ON4F12P2
  64. Crystal structure of cyclo[tetra(μ2-cyanido)-tetracyanido-bis(1,4,7,10-tetraazacyclododecane-κ4N,N′,N′′,N′′′)dinickel(II)dipalladium(II)] hexahydrate, C24H52N16Ni2O6Pd2
  65. Crystal structure of (dimethyl sulfoxide)-dioxido-[2-hydroxy-N′-(4-oxo-4-phenylbutan-2-ylidene)benzohydrazidato κ3N,O,O′]molybdenum(VI), C19H20MoN2O6S
  66. Crystal structure of bis(acetylacetonato-κ2O,O′)-(ethanolamine-κ2N,O)copper(II), C14H25CuNO5
  67. Crystal structure of chlorido-diphenyl-(isopropyl(propyl)carbamodithioato-κ2S,S′)tin(IV), C19H24ClNS2Sn
  68. The crystal structure of bis(imidazole-1-yl)methane monohydrate, C7H10N4O
  69. The crystal structure of bis(4-nitroimidazole-1-1yl)methane, C7H6N6O4
  70. Crystal structure of di(naphthalen-2-yl)sulfane, C20H14S
  71. Crystal structure of 3-acetyl-6-bromo-4-hydroxy-2H-chromen-2-one, C11H7BrO4
  72. Crystal structure of N′2,N′6-bis((E)-1-(pyrazin-2-yl)ethylidene)pyridine-2,6-dicarbohydrazide — methanol (1/2), C21H25N9O4
  73. The crystal structure of 3-nitro-4-(p-tolylamino)-2H-chromen-2-one, C16H12N2O4
  74. The crystal structure of 1,2-bis((4-methoxyphenyl)ethynyl)benzene, C24H18O2
  75. Crystal structure of a low-temperature (100 K) polymorph of catena-poly[(μ2-4,4′-bipyridine-κ2N,N′)-bis(O,O′-diethyldithiophosphato-κ1S)zinc(II)], C18H28N2O4P2S4Zn
  76. The pseudosymmetric low temperature polymorph of catena-poly[(μ2-4,4′-bipyridyl-κN,N′)-bis(O,O′-diethyldithiophosphato-κS)-cadmium(II)], {C18H28CdN2O4P2S4}n
  77. Crystal structure of 3-iodophthalic acid, C8H5IO4
  78. The crystal structure of tert-butyl (tert-butoxy(oxo)methyl)(5-bromo-2-fluorophenyl)carbamate, C16H21BrFNO4
  79. The crystal structure of bis(μ2-5,7-dichloroquinolin-8-olato-κ3N,O:O)-tetrakis(5,7-dichloroquinolin-8-olato-κ2N,O)bis(methanol-κ1O)dieuropium(III) — toluene (1/1), C63H39Cl12Eu2N6O8
  80. Crystal structure of dichlorido-(N′-(1-(3-ethylpyrazin-2-yl)ethylidene)-4-methoxybenzohydrazide-κ3N,N′,O)cadmium(II), C16H18N4O2Cl2Cd
  81. A redetermination of the crystal structure of catena-poly[(bis(O,O′-isopropyl dithiophosphato-κ2S,S′)-(μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N,N′)cadmium(II)], {C24H38CdN4O4P2S4}n
Downloaded on 9.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0600/html
Scroll to top button